Association between delayed outbreak identification and SARS-CoV-2 infection and mortality among long-term care home residents, Ontario, Canada, March to November 2020: a cohort study.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 11 10 2024
Statut: ppublish

Résumé

BackgroundLate outbreak identification is a common risk factor mentioned in case reports of large respiratory infection outbreaks in long-term care (LTC) homes.AimTo systematically measure the association between late SARS-CoV-2 outbreak identification and secondary SARS-CoV-2 infection and mortality in residents of LTC homes.MethodsWe studied SARS-CoV-2 outbreaks across LTC homes in Ontario, Canada from March to November 2020, before the COVID-19 vaccine rollout. Our exposure (late outbreak identification) was based on cumulative infection pressure (the number of infectious resident-days) on the outbreak identification date (early: ≤ 2 infectious resident-days, late: ≥ 3 infectious resident-days), where the infectious window was -2 to +8 days around onset. Our outcome consisted of 30-day incidence of secondary infection and mortality, based on the proportion of at-risk residents with a laboratory-confirmed SARS-CoV-2 infection with onset within 30 days of the outbreak identification date.ResultsWe identified 632 SARS-CoV-2 outbreaks across 623 LTC homes. Of these, 36.4% (230/632) outbreaks were identified late. Outbreaks identified late had more secondary infections (10.3%; 4,437/42,953) and higher mortality (3.2%; 1,374/42,953) compared with outbreaks identified early (infections: 3.3%; 2,015/61,714; p < 0.001, mortality: 0.9%; 579/61,714; p < 0.001). After adjustment for 12 LTC home covariates, the incidence of secondary infections in outbreaks identified late was 2.90-fold larger than that of outbreaks identified early (OR: 2.90; 95% CI: 2.04-4.13).ConclusionsThe timeliness of outbreak identification could be used to predict the trajectory of an outbreak, plan outbreak measures and retrospectively provide feedback for quality improvement, with the objective of reducing the impacts of respiratory infections in LTC home residents.

Identifiants

pubmed: 39391999
doi: 10.2807/1560-7917.ES.2024.29.41.2300719
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Kevin A Brown (KA)

Public Health Ontario, Toronto, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Sarah A Buchan (SA)

Public Health Ontario, Toronto, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
The Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada.

Adrienne K Chan (AK)

Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Division of Infectious Diseases, Sunnybrook Research Institute, Toronto, Canada.
Department of Medicine, University of Toronto, Toronto, Canada.

Andrew Costa (A)

McMaster University, Hamilton, Canada.

Nick Daneman (N)

Public Health Ontario, Toronto, Canada.
The Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada.
Division of Infectious Diseases, Sunnybrook Research Institute, Toronto, Canada.
Department of Medicine, University of Toronto, Toronto, Canada.

Gary Garber (G)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Michael Hillmer (M)

The Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada.
Ontario Ministry of Health, Toronto, Canada.

Aaron Jones (A)

McMaster University, Hamilton, Canada.

James M Johnson (JM)

Public Health Ontario, Toronto, Canada.

Dylan Kain (D)

Department of Medicine, University of Toronto, Toronto, Canada.

Kamil Malikov (K)

Ontario Ministry of Health, Toronto, Canada.

Richard G Mather (RG)

Public Health Ontario, Toronto, Canada.
Department of Family Medicine, Queen's University, Kingston, Canada.

Allison McGeer (A)

Sinai Health, Toronto, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

Kevin L Schwartz (KL)

Public Health Ontario, Toronto, Canada.
St. Joseph's Health System, Toronto, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Nathan M Stall (NM)

Sinai Health, Toronto, Canada.
Women's College Hospital, Toronto, Canada.

Jennie Johnstone (J)

Sinai Health, Toronto, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH